Search Results - "Lomax, Anna J."

Acute management of autoimmune toxicity in cancer patients on immunotherapy: Common toxicities and the approach for the emergency physician by Lomax, Anna J, McNeil, Catriona

“…When a patient receiving anti‐cancer treatment presents acutely unwell, an understanding of associated side effects of their therapy is critical. This review…”
Get full text

Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management by McNeil, Catriona, Chua, Elizabeth, McGill, Neil, Lowe, Patricia, Sweeting, Arianne, Cheng, Robert, Lim, Jennifer, Lomax, Anna J., Shackel, Nicholas

“…Immune checkpoint inhibitors (anti-PD-1 and anti-CTLA-4 antibodies) are a standard of care for advanced melanoma. Novel toxicities comprise immune-related…”
Get full text

Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial by Long, Georgina V, Atkinson, Victoria, Cebon, Jonathan S, Jameson, Michael B, Fitzharris, Bernie M, McNeil, Catriona M, Hill, Andrew G, Ribas, Antoni, Atkins, Michael B, Thompson, John A, Hwu, Wen-Jen, Hodi, F Stephen, Menzies, Alexander M, Guminski, Alexander D, Kefford, Richard, Kong, Benjamin Y, Tamjid, Babak, Srivastava, Archana, Lomax, Anna J, Islam, Mohammed, Shu, Xinxin, Ebbinghaus, Scot, Ibrahim, Nageatte, Carlino, Matteo S

“…Reduced-dose nivolumab in combination with standard-dose ipilimumab improves objective response and progression-free survival compared with standard-dose…”
Get full text

A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability by Lacey, Judith, Lomax, Anna J., McNeil, Catriona, Marthick, Michael, Levy, David, Kao, Steven, Nielsen, Theresa, Dhillon, Haryana M.

“…Introduction Increasing numbers of metastatic melanoma (MM) patients are receiving immunotherapy treatment, including pembrolizumab, and the impact on their…”
Get full text

Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report by Lim, Jennifer, Lomax, Anna J, McNeil, Catriona, Harrisberg, Brian

“…To report the diagnosis of acute VKH-like syndrome as a complication from dabrafenib (a serine/threonine inhibitor of BRAF V600) and trametinib (a MEK…”
Get full text

Immunotherapy‐induced sarcoidosis in patients with melanoma treated with PD‐1 checkpoint inhibitors: Case series and immunophenotypic analysis by Lomax, Anna J., McGuire, Helen M., McNeil, Catriona, Choi, Clara J., Hersey, Peter, Karikios, Deme, Shannon, Kerwin, Hal, Sebastian, Carr, Urszula, Crotty, Anne, Gupta, Sandeep K., Hollingsworth, Jane, Kim, Haewon, Fazekas de St Groth, Barbara, McGill, Neil

“…Aim Sarcoidosis is a multisystem granulomatous disease. This condition has a documented association with the diagnosis of melanoma and can be induced in…”
Get full text

A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers by Roohullah, Aflah, Cooper, Adam, Lomax, Anna J., Aung, Jennifer, Barge, Alan, Chow, Lilian, McHale, Mark, Desai, Jayesh, Whittle, James R., Tran, Ben, de Souza, Paul, Horvath, Lisa G.

“…Summary Background The MET tyrosine kinase and its ligand, hepatocyte growth factor (HGF) also known as scatter factor, are associated with tumourigenesis and…”
Get full text

Bullous pemphigoid-like reaction in a patient with metastatic melanoma receiving pembrolizumab and previously treated with ipilimumab by Lomax, Anna J, Ge, Ludi, Anand, Sunaina, McNeil, Catriona, Lowe, Patricia

Get full text

Acute toxic epidermal necrolysis reaction post single dose pembrolizumab with preceding cephalosporin exposure: successful rechallenge with anti‐PD‐1 therapy by Lomax, Anna J., McQuillan, Peter I. A., Hall, Anthony, McArthur, Grant A.

Get full text

Clinical Nurse Consultant Support: Management of Patients With Melanoma Receiving Immunotherapy 
and Targeted Therapy by Lomax, Anna J, Nielsen, Theresa, Visintin, Lydia, O'Carrigan, Brent, Honeyball, Florian, Shum, Benjamin, Saw, Robyn P M, McNeil, Catriona

“…Targeted therapy and immunotherapy agents for advanced melanoma are associated with novel toxicities. Melanoma clinical nurse consultants (CNCs) provide…”
Get full text

Spinal cord metastasis in a patient treated with bevacizumab for glioblastoma by Lomax, Anna J., Yannakou, Costas K., Rosenthal, Mark A.

“…Spinal metastases from glioblastoma are extremely rare and may be misdiagnosed leading to a delay in investigation and treatment. Patient outcomes are poor…”
Get full text

Case report of interstitial nephritis induced by bevacizumab therapy for glioblastoma multiforme by Lomax, Anna J, Hill, Prue A, Ashley, David M

“…Glioblastoma multiforme is an aggressive malignant brain tumor. The monoclonal antibody, bevacizumab, is active in recurrent disease via inhibition of…”
Get full text

Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial by Lomax, Anna J, Yee Yap, Saw, White, Karen, Beith, Jane, Abdi, Ehtesham, Broad, Adam, Sewak, Sanjeev, Lee, Chooi, Sambrook, Philip, Pocock, Nicholas, Henry, Margaret J, Yeow, Elaine G, Bell, Richard

“…Abstract Postmenopausal women on aromatase inhibitors (AI) are at risk of aromatase inhibitor-associated bone loss (AIBL) and fractures. In 2005 Osteoporosis…”
Get full text

Acute toxic epidermal necrolysis reaction post single dose pembrolizumab with preceding cephalosporin exposure: successful rechallenge with anti-PD-1 therapy by Lomax, Anna J, McQuillan, Peter I A, Hall, Anthony, McArthur, Grant A

Get full text